Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Evidence-based approach to cholangiocarcinoma: a systemic review of current literature.J Am Coll Surg. 2009; 208: 134-147
- Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.Hepatology. 2001; 33: 1353-1357
- Guidelines for diagnosis and management of intrahepatic cholangiocarcinoma.J Hepatol. 2014; 60: 1268-1289
- Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.Cancer Res. 2014; 74: 2913-2921
- Cholangiocarcinoma: thirty-one year experience with 564 patients at a s single institution.Ann Surg. 2007; 245: 755-762
- Clinical diagnosis and staging of cholangiocarcinoma.Nat Rev Gastroenterol Hepatol. 2011; : 512-522
- Intrahepatic peripheral cholangiocarcinoma: CT evaluation.Abdom Imaging. 2000; 25: 490-496
- Contrast enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study.J Magn Reson Imaging. 1995; 5: 165-170
- Intrahepatic cholangiocarcinoma: current perspectives.Onco Targets Ther. 2017; : 1131-1142
- The utility of CA 19-9 in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.Am J Gastroenterol. 2000; 95: 204-207
- Surgical Treatment of intrahepatic cholangiocarcinoma in the USA.J Hepatobiliary Pancreat Sci. 2014; 22: 124-130
- Current update on combined hepatocellular-cholangiocarcinoma.Eur J Radiol Open. 2014; 1: 40-48
- Intrahepatic cholangiocarcinoma: expert consensus statement.HPB (Oxford). 2015; 17: 669-680
- Surgical approach for long term survival of patients with intrahepatic cholangiocarcinoma a multi-institutional analysis of 434 patients.Arch Surg. 2012; 147: 1107-1113
- Peripheral cholangiocarcinoma: presentation, diagnosis, pathology, and management.Eur J Surg Oncol. 1999; 25: 375-380
- Intrahepatic cholangiocarcinoma: rising frequency, improved survival and determinants of outcome after resection.Ann Surg. 2008; 243: 84-96
- Intrahepatic cholangiocarcinoma the AJCC/UICC 8th edition updates.Chin Clin Oncol. 2018; 7: 1-5
- Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma.Surg Enodsc. 2006; 20: 721-725
- The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases.Ann Surg Oncol. 2003; 10: 183-189
- Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis.J Surg Oncol. 2017; 116: 643-650
- Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.J Clin Oncol. 2011; 29: 3140-3145
- Trends in survival after surgery for cholangiocarcinoma: a 30 year population based SEER database analysis.J Gastrointest Surg. 2007; 11: 1488-1497
- Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta analysis.JAMA Surg. 2014; 149: 565-574
- Intrahepatic cholangiocarcinoma: an international multi-institution analysis of prognostic factors and lymph node assessment.J Clin Oncol. 2001; 29: 3140-3145
- The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection on survival.Ann Surg Oncol. 2009; 16: 3048-3056
- Capecitabine compared with observation in resected biliary tract cancer( BILCAP): a randomized, controlled, multicenter, phase 3 study.Lancet Oncol. 2019; 20: 663-673
- Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.N Engl J Med. 2010; 362: 1273-1281
- Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.BMC Cancer. 2010; 10: 492
- Clinical outcome toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.Radiat Oncol. 2012; 7: 67
- Transarterial chemoembolization versus supportive therapy in palliative treatment of resectable intrahepatic cholangiocarcinoma.Clin Radiol. 2011; 66: 322-328
- Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.Eur J Gastroenterol Hepatol. 2012; 24: 437-443
- Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.Cancer. 2008; 113: 2119-2128
- Multidisciplinary approaches to intrahepatic cholangiocarcinoma.Cancer. 2013; 119: 3929-3942
- Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.AJR AM J Roentgenol. 2011; 196: W205-W209
- Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival compared to systemic chemotherapy alone.Cancer. 2016; 122: 758-765
- Precision medicine in cholangiocarcinoma.Transl Gastroenterol Hepatol. 2018; 3: 40
- Cancer statistics, 2019.Cancer J Clin. 2019; 69: 7-34
- Management of hepatocellular carcinoma: an update.Hepatology. 2011; 53: 1020-1022
- Futures of hepatocellular carcinoma incidence in the United States forecast through 2030.J Clin Oncol. 2016; 34: 1787-1794
- Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.World J Gastroenterol. 2007; 13: 414-420
- The etiology of hepatocellular carcinoma and consequences for treatment.Oncologist. 2010; 15: 14-22
- Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases.Hepatology. 2018; 68: 723-750
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study.Hepatology. 2016; 63: 827-838
- Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease.Hepatology. 2012; 55: 1809-1819
- Inadequate hepatocellular carcinoma screening in patients with nonalcoholic steatohepatitis cirrhosis.J Clin Gastroenterol. 2019; 53: 142-146
- The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.Hepatology. 2017; 67: 328-357
- The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.Hepatology. 2007; 45: 846-854
- Incidence and risk factors associated with hepatocellular carcinoma surveillance failure.J Gastroenterol Hepatol. 2018; 33: 1524-1529
- Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.Ann Intern Med. 2003; 139: 46-50
- Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.Gastroenterology. 1984; 86: 1404
- Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy—a systematic review.Gastroenterology. 2019; 159
- NCCN.(Available at:)https://www.nccn.org/(Accessed July 16, 2019.)Date: 2019
- Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.Ann Surg. 2007; 245: 435-442
- Intratumor heterogeneity in hepatocellular carcinoma.Clin Cancer Res. 2015; 21: 1951-1961
- Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease.Surg Oncol Clin N Am. 2003; 12: 51-63
- Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.Hepatology. 1999; 30: 1434-1440
- Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.Radiology. 2008; 247: 260-266
- Surgical resection of high-risk hepatocellular carcinoma; patient selection, preoperative considerations, and operative technique.Ann Surg Oncol. 2010; 17: 1219-1225
- Liver transplantation for the treatment of small hepatocellular carcinomas in patient with cirrhosis.N Engl J Med. 1996; 334: 693
- A model to predict survival in patients with end stage liver disease.Hepatology. 2001; 33: 464
- Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system.Am J Transplant. 2010; 10: 1643-1648
Organ Procurement and Transplantation Network (OPTN). Allocation of liver and liver-intestines. Available at: https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf. Accessed April 6, 2020.
- Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.Aliment Pharmacol Ther. 2018; 48: 671-681
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial.Lancet. 2002; 359: 1734
- Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: a systematic review and meta-analysis.World J Hepatol. 2016; 8: 770-778
- Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis.Int J Radiat Oncol Biol Phys. 2016; 95: 477
- Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma.J Clin Oncol. 2016; 452: 34
- Sorafenib in advanced hepatocellular carcinoma.N Engl J Med. 2008; 359: 378-390
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma; a randomized phase 3 non-inferiority trial.Lancet. 2018; 391: 1163
Article info
Publication history
Published online: April 16, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
